Vitamin-D levels in COVID-19 Patients and their relationship with other bone metabolism markers
Not yet recruiting
- Conditions
- Coronavirus as the cause of diseases classified elsewhere,
- Registration Number
- CTRI/2020/07/026794
- Lead Sponsor
- AIIMS Raipur
- Brief Summary
Vitamin D has been found to affect the outcome of a patient with COVID 19 affection. It has been found that low levels of serum Vitamin D levels in a patient with COVID 19 symptoms has a poor outcome. This study is planned to find out the incidence of serum Vitamin D deficiency in COVID 19 patients and its relation with markers of bone metabolism.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Consecutive patientsPatients giving voluntary consent for participation in the study.
Exclusion Criteria
Non COVID 19 Patients Patients not admitted in COVID 19 ward Patients not giving a consent for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Does Bone metabolism as judged by serum Calcium, phosphorous, alkaline phosphatase and serum Vitamin D levels get altered in COVID 19 patients? at 6 months
- Secondary Outcome Measures
Name Time Method Incidence of hypovitaminosis D in COVID 19 patients in India 6 months duration of sample collection on 100 COVID 19 positive patients
Trial Locations
- Locations (1)
AIIMS Raipur
🇮🇳Raipur, CHHATTISGARH, India
AIIMS Raipur🇮🇳Raipur, CHHATTISGARH, IndiaDr Alok Chandra AgrawalPrincipal investigator9425151634dralokcagrawal@gmail.com